Skip to content
value.today

Simpirica Spine, Inc.

Total raised
$20 M
2 rounds on record
Latest round
$5 M
Dec 2013
First round on record
Sep 2011
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Simpirica Spine, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2013$5 MNo. 2$2 to $10 million

Simpirica Spine, Inc.: Raise no. 2, Dec 2013

Investors in this round

3 investors had bought by the notice of Jan 22, 2014: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $6 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jan-Peter Heldt · Executive Officer, Director
  • Jeffrey Schwardt · Executive Officer
  • Casper de Clercq · Director
  • David Mauney · Director
  • Richard Ferrari · Director
  • Todd Alamin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jan Peter Heldt, President & CEO. Source: SEC Form D, newest notice filed Jan 22, 2014. Read the notice at the SEC.

debt, optionsSEC
Sep 2011$15 MNo. 1$10 to $50 million

Simpirica Spine, Inc.: Raise no. 1, Sep 2011

Investors in this round

4 investors had bought by the notice of Sep 22, 2011: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $23 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Austin F. Noll, III · Executive Officer, Director
  • John Colin Cahill · Executive Officer, Director
  • Casper Colin de Clercq · Director
  • David Colin Mauney · Director
  • Phil Colin Young · Director
  • Richard Colin Ferrari · Director
  • Todd Colin Alamin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Consideration in part was cancellation of debt and conversion of interest on the debt in the aggregate amount of $7,535,066. The balance of consideration was cash.”

Signed by Austin F. Noll, III, President and CEO. Source: SEC Form D, newest notice filed Sep 22, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Simpirica Spine, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2014).

    SEC Form D · Jan 2014

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jan 2014

That is all the official record says: Simpirica Spine, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Simpirica Spine, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 4 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Simpirica Spine, Inc.
NameRoleNamed in
Jan-Peter HeldtExecutive officerJan 2014
Jeffrey SchwardtExecutive officerJan 2014
Austin F. Noll, IIIExecutive officerSep 2011
John Colin CahillExecutive officerSep 2011
Casper de ClercqDirectorJan 2014
David MauneyDirectorJan 2014
Jan-Peter HeldtDirectorJan 2014
Richard FerrariDirectorJan 2014
Todd AlaminDirectorJan 2014
Austin F. Noll, IIIDirectorSep 2011
Casper Colin de ClercqDirectorSep 2011
David Colin MauneyDirectorSep 2011
John Colin CahillDirectorSep 2011
Phil Colin YoungDirectorSep 2011
Richard Colin FerrariDirectorSep 2011
Todd Colin AlaminDirectorSep 2011